The Lancet Neurology in conversation with

The Lancet Group

Subscribe in Parasocial

Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.

About

Explore the latest breakthroughs in brain health and neurological disease through interviews with leading researchers, neurologists, and policy experts. Each episode breaks down complex topics for a broad audience, translating cutting-edge science into practical insights. Editors at The Lancet Neurology, the world-leading clinical neurology journal, interview the investigators at the forefront of stroke, Alzheimer’s disease, epilepsy, migraine, Parkinson’s disease, multiple sclerosis, sleep disorders, traumatic brain injury, and other neurological challenges.

Also on

Recent episodes

  • The future of Alzheimer’s disease: blood biomarkers, brain imaging, and screening the cognitively unimpairedSep 9, 2026 · 29 min
  • Marjo van der Knaap on vanishing white matterAug 12, 2026 · 17 min
  • Jan D Lünemann and Christian Münz on Epstein–Barr virus and multiple sclerosisJul 15, 2026 · 16 min
  • Hal Dietz discusses the role of genetics in spinal CSF leaksJun 17, 2026 · 16 min
  • Tony Schapira on GBA1 Parkinson's diseaseJun 16, 2026 · 26 min
  • Henry Brodaty and Alice Powell on cognitive resilience and ageingApr 17, 2026 · 23 min
  • Niklas Mattsson-Carlgren on the use of biomarkers in the diagnosis and stratification of Alzheimer’s diseaseMar 18, 2026 · 16 min
  • Cristina Tassorelli on migraine preventionFeb 18, 2026 · 24 min
  • Inga Zerr and Simon Mead on advances in prion diseasesJan 21, 2026 · 30 min
  • Julia Greenland on azathioprine for early Parkinson’s diseaseDec 19, 2025 · 15 min

Website · RSS feed

The Lancet Neurology in conversation with | Parasocial